Skip to Main Content
CKG
Home
Home
Home
TKG
Author details
Breadcrumb
Author Details
Full Name
Pierre P Massion
Affiliation
Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center
ORCID
Career Start Year
1993
Papers
223
H Index
58
Expertise
CM4AI Collaborator
PMID
Paper Title
Journal Title
Published Year
36368616
Development and Validation of a Risk Assessment Model for Pulmonary Nodules Using Plasma Proteins and Clinical Factors.
Chest
2023
36368616
Development and Validation of a Risk Assessment Model for Pulmonary Nodules Using Plasma Proteins and Clinical Factors.
Chest
2023
37760474
Validation of a Proteomic Signature of Lung Cancer Risk from Bronchial Specimens of Risk-Stratified Individuals.
Cancers (Basel)
2023
37848457
Cancer-associated fibroblasts in early-stage lung adenocarcinoma correlate with tumor aggressiveness.
Sci Rep
2023
37674811
Tumoral Densities of T-Cells and Mast Cells Are Associated With Recurrence in Early-Stage Lung Adenocarcinoma.
JTO Clin Res Rep
2023
37612638
TP53 mutation prevalence in normal airway epithelium as a biomarker for lung cancer risk.
BMC Cancer
2023
37016707
Biomarkers in Lung Cancer Screening: a Narrative Review.
Curr Chall Thorac Surg
2023
36630482
Posttranslational modifications induce autoantibodies with risk prediction capability in patients with small cell lung cancer.
Sci Transl Med
2023
37760474
Validation of a Proteomic Signature of Lung Cancer Risk from Bronchial Specimens of Risk-Stratified Individuals.
Cancers (Basel)
2023
37848457
Cancer-associated fibroblasts in early-stage lung adenocarcinoma correlate with tumor aggressiveness.
Sci Rep
2023
37612638
TP53 mutation prevalence in normal airway epithelium as a biomarker for lung cancer risk.
BMC Cancer
2023
37674811
Tumoral Densities of T-Cells and Mast Cells Are Associated With Recurrence in Early-Stage Lung Adenocarcinoma.
JTO Clin Res Rep
2023
37016707
Biomarkers in Lung Cancer Screening: a Narrative Review.
Curr Chall Thorac Surg
2023
36630482
Posttranslational modifications induce autoantibodies with risk prediction capability in patients with small cell lung cancer.
Sci Transl Med
2023
35294486
18F-FSPG PET imaging for the evaluation of indeterminate pulmonary nodules.
PLoS One
2022
35763345
Ligand-independent integrin β1 signaling supports lung adenocarcinoma development.
JCI Insight
2022
35748739
Genomic Profiling of Bronchoalveolar Lavage Fluid in Lung Cancer.
Cancer Res
2022
35491773
The impact of the lung EDRN-CVC on Phase 1, 2, & 3 biomarker validation studies.
Cancer Biomark
2022
35941262
cfDNA methylome profiling for detection and subtyping of small cell lung cancers.
Nat Cancer
2022
35870539
Improving malignancy risk prediction of indeterminate pulmonary nodules with imaging features and biomarkers.
Clin Chim Acta
2022
35413280
The Association of Health Care System Resources With Lung Cancer Screening Implementation: A Cohort Study.
Chest
2022
35608444
Artificial Intelligence Tool for Assessment of Indeterminate Pulmonary Nodules Detected with CT.
Radiology
2022
36120008
Assay Performance of a Label-Free, Solution-Phase CYFRA 21-1 Determination.
ACS Omega
2022
35332150
Integrative network analysis of early-stage lung adenocarcinoma identifies aurora kinase inhibition as interceptor of invasion and progression.
Nat Commun
2022
35294486
18F-FSPG PET imaging for the evaluation of indeterminate pulmonary nodules.
PLoS One
2022
35033300
Association of Rurality With Annual Repeat Lung Cancer Screening in the Veterans Health Administration.
J Am Coll Radiol
2022
35158979
Early-Stage Lung Adenocarcinoma MDM2 Genomic Amplification Predicts Clinical Outcome and Response to Targeted Therapy.
Cancers (Basel)
2022
35608444
Artificial Intelligence Tool for Assessment of Indeterminate Pulmonary Nodules Detected with CT.
Radiology
2022
35763345
Ligand-independent integrin β1 signaling supports lung adenocarcinoma development.
JCI Insight
2022
35491773
The impact of the lung EDRN-CVC on Phase 1, 2, & 3 biomarker validation studies.
Cancer Biomark
2022
35748739
Genomic Profiling of Bronchoalveolar Lavage Fluid in Lung Cancer.
Cancer Res
2022
35413280
The Association of Health Care System Resources With Lung Cancer Screening Implementation: A Cohort Study.
Chest
2022
35941262
cfDNA methylome profiling for detection and subtyping of small cell lung cancers.
Nat Cancer
2022
35870539
Improving malignancy risk prediction of indeterminate pulmonary nodules with imaging features and biomarkers.
Clin Chim Acta
2022
36120008
Assay Performance of a Label-Free, Solution-Phase CYFRA 21-1 Determination.
ACS Omega
2022
35158979
Early-Stage Lung Adenocarcinoma MDM2 Genomic Amplification Predicts Clinical Outcome and Response to Targeted Therapy.
Cancers (Basel)
2022
35033300
Association of Rurality With Annual Repeat Lung Cancer Screening in the Veterans Health Administration.
J Am Coll Radiol
2022
35332150
Integrative network analysis of early-stage lung adenocarcinoma identifies aurora kinase inhibition as interceptor of invasion and progression.
Nat Commun
2022
32682756
Validation of Histoplasmosis Enzyme Immunoassay to Evaluate Suspicious Lung Nodules.
Ann Thorac Surg
2021
35813245
Integrated Cells and Collagen Fibers Spatial Image Analysis.
Front Bioinform
2021
33640962
Incorporating both genetic and tobacco smoking data to identify high-risk smokers for lung cancer screening.
Carcinogenesis
2021
33618009
A model based on the quantification of complement C4c, CYFRA 21-1 and CRP exhibits high specificity for the early diagnosis of lung cancer.
Transl Res
2021
33827979
Small airway determinants of airflow limitation in chronic obstructive pulmonary disease.
Thorax
2021
34257356
HLA-DR cancer cells expression correlates with T cell infiltration and is enriched in lung adenocarcinoma with indolent behavior.
Sci Rep
2021
34354325
Measure Partial Liver Volumetric Variations from Paired Inspiratory-expiratory Chest CT Scans.
Proc SPIE Int Soc Opt Eng
2021
33973553
Risk stratification of indeterminate pulmonary nodules.
Curr Opin Pulm Med
2021
33303552
Validation of the BRODERS classifier (Benign <i>versus</i> aggRessive nODule Evaluation using Radiomic Stratification), a novel HRCT-based radiomic classifier for indeterminate pulmonary nodules.
Eur Respir J
2021
33141593
Reply to Wilson: Risk-Stratifying Pulmonary Nodules.
Am J Respir Crit Care Med
2021
32682756
Validation of Histoplasmosis Enzyme Immunoassay to Evaluate Suspicious Lung Nodules.
Ann Thorac Surg
2021
33422974
Protocol to evaluate an enterprise-wide initiative to increase access to lung cancer screening in the Veterans Health Administration.
Clin Imaging
2021
1 - 50 of 446
Column Actions
Search
Recommended Authors
Zisheng Chen
The Sixth Affiliated Hospital of Guangzhou Medical University
Career Start Year
2018
Number of shared co-authors
0
Dijana Djureinovic
Yale University School of Medicine
Career Start Year
2014
Number of shared co-authors
0
Yi Zhao
the First Affiliated Hospital of Guangzhou Medical University
Career Start Year
2013
Number of shared co-authors
1
Mich??le Orain
Institut Universitaire de Cardiologie et de Pneumologie de Quebec, Universite Laval
Career Start Year
2013
Number of shared co-authors
0
Zhixin Qiu
UPMC Hillman Cancer Center
Career Start Year
2012
Number of shared co-authors
0
Jianjun Zhang
The University of Texas MD Anderson Cancer Center
Career Start Year
2012
Number of shared co-authors
11
Jyoti Malhotra
Rutgers Cancer Institute of New Jersey, Robert Wood Johnson Medical School
Career Start Year
2012
Number of shared co-authors
2
Shaolei Li
Peking University Cancer Hospital & Institute
Career Start Year
2012
Number of shared co-authors
0
Siddhartha Devarakonda
Siteman Cancer Center, Washington University School of Medicine
Career Start Year
2011
Number of shared co-authors
7
Fei Li
Shanghai Pulmonary Hospital, Tongji University School of Medicine
Career Start Year
2010
Number of shared co-authors
3
Karolina Edlund
Leibniz Research Centre for Working Environment and Human Factors at TU Dortmund
Career Start Year
2008
Number of shared co-authors
0
Shingo Sakashita
National Cancer Center Exploratory Oncology Research & Clinical Trial Center
Career Start Year
2008
Number of shared co-authors
1
Matthew J Cecchini
Western University
Career Start Year
2008
Number of shared co-authors
1
Xi Liu
College of Biology and Food, Shangqiu Normal University
Career Start Year
2007
Number of shared co-authors
8
Yang Xie
Quantitative Biomedical Research Center
Career Start Year
2007
Number of shared co-authors
7
Chi Young Jung
Daegu Catholic University Medical Center
Career Start Year
2006
Number of shared co-authors
1
Esther Herpel
Institute of Pathology, University Hospital Heidelberg
Career Start Year
2005
Number of shared co-authors
1
Wenhua Liang
The First People's Hospital of Zhaoqing
Career Start Year
2003
Number of shared co-authors
3
Lixia Diao
The University of Texas MD Anderson Cancer Center
Career Start Year
2003
Number of shared co-authors
13
Xin Yang
Peking University Cancer Hospital & Institute
Career Start Year
2002
Number of shared co-authors
0
Ni Liu
Princess Margaret Cancer Centre, University Health Network, University of Toronto
Career Start Year
1997
Number of shared co-authors
1
Patrick Micke
Uppsala University
Career Start Year
1997
Number of shared co-authors
0
Chang-Qi Zhu
Princess Margaret Cancer Centre, University Health Network
Career Start Year
1996
Number of shared co-authors
3
Jorge Nieva
Norris Comprehensive Cancer Center, University of Southern California
Career Start Year
1995
Number of shared co-authors
2
Jianxing He
Guangzhou Medical University, First Hospital
Career Start Year
1994
Number of shared co-authors
5
Geoffrey Liu
The Princess Margaret Cancer Centre/University of Toronto
Career Start Year
1992
Number of shared co-authors
12
David N Watkins
Research Institute in Oncology and Hematology
Career Start Year
1991
Number of shared co-authors
8
David S Schrump
Center for Cancer Research, National Cancer Institute
Career Start Year
1988
Number of shared co-authors
7
Hans Brunnstr??m
Lund University
Career Start Year
1977
Number of shared co-authors
6
Ming-Sound Tsao
University Health Network, University of Toronto
Career Start Year
1972
Number of shared co-authors
26
row(s) 1 - 30 of 30
Collaborators
Eric L Grogan
Veterans Affairs Tennessee Valley Healthcare System
Co-authored papers
31
Stephen A Deppen
Vanderbilt University Medical Center
Co-authored papers
29
Bennett A Landman
Vanderbilt University
Co-authored papers
15
Michael N Kammer
Vanderbilt University Medical Center
Co-authored papers
11
Richard M Caprioli
Mass Spectrometry Research Center, Vanderbilt University
Co-authored papers
10
Robert S Dittus
12328Vanderbilt University Medical Center
Co-authored papers
9
Carol Callaway-Lane
Tennessee Valley Healthcare System
Co-authored papers
9
John D Minna
University of Texas Southwestern Medical Center at Dallas
Co-authored papers
8
Jonathan C Nesbitt
Vanderbilt University Medical Center
Co-authored papers
8
Christianne L Roumie
Vanderbilt University Medical Center
Co-authored papers
8
John T Poirier
Laura and Isaac Perlmutter Cancer Center
Co-authored papers
7
Jennifer A Lewis
Vanderbilt-Ingram Cancer Center
Co-authored papers
7
Charles M Rudin
Memorial Sloan Kettering Cancer Center
Co-authored papers
7
Avrum Spira
Boston University School of Medicine
Co-authored papers
6
Lisa J Zimmerman
Co-authored papers
6
Daniel C Liebler
Co-authored papers
6
Lucy B Spalluto
Vanderbilt-Ingram Cancer Center, and Education Clinical Center (GRECC)
Co-authored papers
6
Julien Sage
Department of Pediatrics Stanford University Stanford California USA.
Co-authored papers
5
Chad V Pecot
University of North Carolina at Chapel Hill
Co-authored papers
4
Amelia W Maiga
Vanderbilt University Medical Center
Co-authored papers
4
Jing Wang
Co-authored papers
4
Robbert J C Slebos
Co-authored papers
4
Christopher G Slatore
Health Services Research & Development
Co-authored papers
3
Theodore Speroff
Vanderbilt University Medical Center
Co-authored papers
3
Gerard A Silvestri
Co-authored papers
3
Lifang Hou
Co-authored papers
3
Drew Moghanaki
University of California Los Angeles
Co-authored papers
3
Steven M Dubinett
David Geffen School of Medicine at university of california los angeles
Co-authored papers
3
Lauren R Samuels
Vanderbilt University Medical Center
Co-authored papers
3
Michael Matheny
American College of Medical Informatics, Department of Veteran Affairs, Harvard University T H Chan School of Public Health, Massachusetts Institute of Technology, The American Society for Clinical Investigation, University of Kentucky, Vanderbilt University Medical Center, Vanderbilt University Medical School
Co-authored papers
3
1 - 30